Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
Conditions of optimal recombinant Human SLAMF7/CRACC/CD319 Protein performance should be determined experimentally by the investigator.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
BP005159: Human SLAMF7/CRACC/CD319 Protein with the C-hFc Tag
Source: The recombinant Human SLAMF7/CRACC/CD319 Protein, (amino acids Ser23-Met226) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Human SLAMF7/CRACC/CD319 protein with the hFc tag at the C-terminus has a predicted MW of 49.2 kDa. Due to glycosylation, the protein migrates to 68-80 kDa based on Bis-Tris PAGE result.
Activity: Immobilized recombinant Human SLAMF7 protein with the C-hFc tag at 0.5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Biotinylated Anti-SLAMF7 Antibody protein with the C-hFc tag with the EC50 10.4 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human SLAMF7/CRACC/CD319 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.
BP005508: Human SLAMF7/CRACC/CD319 Protein with the C-mFc Tag
Source: The recombinant Human SLAMF7/CRACC/CD319 Protein, (amino acids Ser23-Met226) fused with a mFc tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Human SLAMF7/CRACC/CD319 protein with the mFc tag at the C-terminus has a predicted MW of 48.8 kDa. Due to glycosylation, the protein migrates to 68-72 kDa based on Bis-Tris PAGE result.
Activity: Immobilized recombinant Human SLAMF7 protein with the C-mFc tag at 1 ug/ml (100 ul/Well). Dose response curve for the recombinant Anti-SLAMF7 Antibody protein with the C-hFc tag with the EC50 of 15.7 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human SLAMF7/CRACC/CD319 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.
BP005402: Human SLAMF7/CRACC/CD319 Protein with the C-His-Avi Tag
Source: The recombinant Human SLAMF7/CRACC/CD319 Protein, (amino acids Ser23-Met226) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Human SLAMF7/CRACC/CD319 protein with the His-Avi tag at the C-terminus has a predicted MW of 25.3 kDa. Due to glycosylation, the protein migrates to 40-55 kDa based on Bis-Tris PAGE result.
Activity: Immobilized recombinant Human SLAMF7 protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-SLAMF7 Antibody protein with the C-hFc tag with the EC50 of 2.2 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Human SLAMF7/CRACC/CD319 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.
Copyright © 2009-2025 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.
Friend Link: Ushelf